# Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.

> **NCT00189956** · PHASE2 · COMPLETED · sponsor: **Bavarian Nordic** · enrollment: 165 (actual)

## Conditions studied

- Smallpox

## Interventions

- **BIOLOGICAL:** IMVAMUNE (MVA-BN)

## Key facts

- **NCT ID:** NCT00189956
- **Lead sponsor:** Bavarian Nordic
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2003-11
- **Final completion:** 2005-12
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2019-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00189956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00189956, "Dose-finding Study to Evaluate Immunogenicity of Three Different Dose Levels of the IMVAMUNE (MVA-BN) Smallpox Vaccine.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00189956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*